SK280564B6 - Injekčný prípravok so spomaleným uvoľňovaním účinn - Google Patents

Injekčný prípravok so spomaleným uvoľňovaním účinn Download PDF

Info

Publication number
SK280564B6
SK280564B6 SK1816-91A SK181691A SK280564B6 SK 280564 B6 SK280564 B6 SK 280564B6 SK 181691 A SK181691 A SK 181691A SK 280564 B6 SK280564 B6 SK 280564B6
Authority
SK
Slovakia
Prior art keywords
microspheres
active substance
injectable preparation
pharmaceutical active
preparation according
Prior art date
Application number
SK1816-91A
Other languages
English (en)
Slovak (sk)
Inventor
Flores J. Garza
Soto L. P. Laiseca
Pichardo J. Guillen
Uribe J. Angeles
Original Assignee
Aplicaciones Farmaceuticas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aplicaciones Farmaceuticas filed Critical Aplicaciones Farmaceuticas
Publication of SK280564B6 publication Critical patent/SK280564B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SK1816-91A 1990-06-14 1991-06-13 Injekčný prípravok so spomaleným uvoľňovaním účinn SK280564B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9007416A FR2663223B1 (fr) 1990-06-14 1990-06-14 Forme galenique parenterale.

Publications (1)

Publication Number Publication Date
SK280564B6 true SK280564B6 (sk) 2000-03-13

Family

ID=9397598

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1816-91A SK280564B6 (sk) 1990-06-14 1991-06-13 Injekčný prípravok so spomaleným uvoľňovaním účinn

Country Status (30)

Country Link
US (3) US5360616A (no)
EP (1) EP0533739B1 (no)
JP (1) JP2675675B2 (no)
KR (1) KR0157439B1 (no)
CN (1) CN1057442C (no)
AT (1) ATE109658T1 (no)
AU (1) AU661275B2 (no)
BG (1) BG61179B1 (no)
BR (1) BR9106545A (no)
CA (1) CA2085344C (no)
CZ (1) CZ286793B6 (no)
DE (1) DE69103419T2 (no)
DK (1) DK0533739T3 (no)
ES (1) ES2059142T3 (no)
FI (1) FI107698B (no)
FR (1) FR2663223B1 (no)
HU (1) HUT68709A (no)
IE (1) IE62679B1 (no)
IL (1) IL98459A (no)
NO (1) NO302998B1 (no)
NZ (1) NZ238542A (no)
PL (1) PL167234B1 (no)
PT (1) PT97975B (no)
RU (1) RU2104692C1 (no)
SK (1) SK280564B6 (no)
TN (1) TNSN91048A1 (no)
UA (1) UA27043C2 (no)
UY (1) UY23240A1 (no)
WO (1) WO1991019484A1 (no)
ZA (1) ZA914550B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663224B1 (fr) * 1990-06-14 1995-01-20 Applicationes Farmaceuticas Sa Forme galenique parenterale.
GB9313642D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
FR2732621B1 (fr) * 1995-04-10 1997-06-06 Rhone Poulenc Chimie Perles d'un produit presentant le phenomene de surfusion et leur procede d'obtention
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US6028057A (en) * 1998-02-19 2000-02-22 Thorn Bioscience, Llc Regulation of estrus and ovulation in gilts
DE69917000T2 (de) * 1998-02-25 2005-04-21 Abbott Lab Butorphanol enthaltende formulierungen mit verzögerter freisetzung
US6287693B1 (en) * 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
CA2382216A1 (en) * 1999-08-20 2001-03-01 Xian Ming Zeng Method to produce powders for pulmonary or nasal administration
US20030055075A1 (en) * 2001-07-13 2003-03-20 Rubsamen Reid M. Programmable controlled release injectable opioid formulation
US20070254009A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic/bone morphogenic protein formulation and method of treatment
US20070254008A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic formulation and method of treatment
GB0117696D0 (en) * 2001-07-20 2001-09-12 Bradford Particle Design Plc Particle information
BRPI0411335A (pt) 2003-06-13 2006-07-25 John Claude Savoir método para preparar uma formulação de estradiol de liberação lenta, formulação farmacêutica, microesferas de estradiol e colesterol, método para efetuar contracepção e terapia de reposição hormonal simultáneas, e, kit
US20050032811A1 (en) 2003-08-06 2005-02-10 Josiah Brown Methods for administering aripiprazole
HUE025239T2 (en) 2003-09-03 2016-03-29 Miscon Trading S A Methods for treating endometriosis
US7205281B2 (en) 2003-10-03 2007-04-17 Thorn Bioscience, Llc Process for the synchronization of ovulation for timed breeding without heat detection
MXPA06004489A (es) 2003-10-23 2006-06-20 Otsuka Pharma Co Ltd Formulacion y metodo de aripiprazol inyectable esteril de liberacion controlada.
US7413690B1 (en) 2003-10-29 2008-08-19 The University Of Mississippi Process and apparatus for producing spherical pellets using molten solid matrices
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
US7392635B2 (en) * 2005-06-09 2008-07-01 Tipper Tie, Inc. Breech loader packaging systems and associated breech loading chutes and methods
US20070197435A1 (en) * 2006-02-17 2007-08-23 Webel Stephen K Process for the synchronization of ovulation for timed breeding without heat detection
ATE475686T1 (de) 2006-10-31 2010-08-15 Surmodics Pharmaceuticals Inc Kugelförmige polymer-teilchen
TWI410255B (zh) 2007-07-31 2013-10-01 Otsuka Pharma Co Ltd 阿立哌唑（Ａｒｉｐｉｐｒａｚｏｌｅ）懸浮液及冷凍乾燥調配物之製法
CA2721509A1 (en) * 2008-04-14 2009-10-22 Posi Visionary Solutions Llp Method and pharmaceutical composition for obtaining the plasmatic progesterone levels required for different therapeutic indications
US8905913B2 (en) 2009-04-23 2014-12-09 Jbs United Animal Health Ii Llc Method and composition for synchronizing time of insemination
UY33103A (es) 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
DK2925339T3 (da) 2012-11-28 2020-07-20 United Ah Ii Llc Fremgangsmåde til synkronisering af inseminationstidspunkt hos gylte
WO2017105512A1 (en) 2015-12-18 2017-06-22 Proinvet Innovations S.A. Formulations and methods for controlling the reproductive cycle and ovulation
AU2017223595B2 (en) * 2016-02-24 2022-11-24 Eastern Virginia Medical School An improved formulation of long-acting levonorgestrel butanoate injectable depot suspension
CN106063783B (zh) * 2016-06-16 2019-03-12 浙江爱生药业有限公司 一种黄体酮缓释微囊制剂及其制备方法
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
CN115212170B (zh) * 2021-04-19 2024-01-26 中国人民解放军军事科学院军事医学研究院 一种致密圆整的药物球形微晶及其制备方法和其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670438A (no) * 1964-10-06 1966-01-31
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3928566A (en) * 1970-08-14 1975-12-23 Du Pont Lyophilized biological products
JPS5017525A (no) * 1973-06-14 1975-02-24
CA1077842A (en) * 1975-10-09 1980-05-20 Minnesota Mining And Manufacturing Company Albumin medicament carrier system
US4244949A (en) * 1978-04-06 1981-01-13 The Population Council, Inc. Manufacture of long term contraceptive implant
US4349580A (en) * 1978-08-18 1982-09-14 Queen's University At Kingston Process and solution for preserving green plant tissues
US4384975A (en) * 1980-06-13 1983-05-24 Sandoz, Inc. Process for preparation of microspheres
US4349530A (en) * 1980-12-11 1982-09-14 The Ohio State University Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
IL79407A (en) * 1985-08-01 1991-03-10 Theragenics Corp System and method for delivering insoluble material into a living body
US4837381A (en) * 1986-08-11 1989-06-06 American Cyanamid Company Compositions for parenteral administration and their use
EP0257368B1 (en) * 1986-08-11 1992-03-25 American Cyanamid Company Compositions for parenteral administration and their use
US4892734A (en) * 1987-04-06 1990-01-09 Endocon, Inc. Dispensing paste for forming medicinal pellets
US4748024A (en) * 1987-04-06 1988-05-31 Endocon, Inc. Flash flow fused medicinal implants
WO1988007816A1 (en) * 1987-04-06 1988-10-20 Endocon, Inc. Flash flow fused medicinal implants
ATE99546T1 (de) * 1989-05-01 1994-01-15 Alkermes Inc Verfahren zur herstellung von kleinen partikeln von biologisch aktiven molekuelen.
US5019400A (en) * 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres

Also Published As

Publication number Publication date
IL98459A (en) 1996-09-12
CS181691A3 (en) 1992-06-17
BG61179B1 (bg) 1997-02-28
PL167234B1 (pl) 1995-08-31
FI925661A (fi) 1992-12-11
US5512303A (en) 1996-04-30
FI107698B (fi) 2001-09-28
NO924792L (no) 1993-02-03
JPH05507694A (ja) 1993-11-04
FR2663223A1 (fr) 1991-12-20
EP0533739A1 (fr) 1993-03-31
DK0533739T3 (da) 1995-01-09
US5360616A (en) 1994-11-01
NO924792D0 (no) 1992-12-11
CA2085344C (en) 1998-06-30
DE69103419T2 (de) 1995-03-30
TNSN91048A1 (fr) 1992-10-25
AU8084791A (en) 1992-01-07
JP2675675B2 (ja) 1997-11-12
ZA914550B (en) 1992-03-25
CN1057961A (zh) 1992-01-22
CA2085344A1 (en) 1991-12-15
IE62679B1 (en) 1995-02-22
NO302998B1 (no) 1998-05-18
US5633014A (en) 1997-05-27
UY23240A1 (es) 1991-07-12
BG97166A (bg) 1993-12-24
WO1991019484A1 (fr) 1991-12-26
NZ238542A (en) 1993-09-27
IE912017A1 (en) 1991-12-18
HU9203958D0 (en) 1993-03-29
PL290677A1 (en) 1992-11-30
FR2663223B1 (fr) 1994-12-02
CN1057442C (zh) 2000-10-18
EP0533739B1 (fr) 1994-08-10
IL98459A0 (en) 1992-07-15
KR0157439B1 (ko) 1998-11-16
RU2104692C1 (ru) 1998-02-20
BR9106545A (pt) 1993-06-01
CZ286793B6 (cs) 2000-07-12
ATE109658T1 (de) 1994-08-15
ES2059142T3 (es) 1994-11-01
FI925661A0 (fi) 1992-12-11
DE69103419D1 (de) 1994-09-15
HUT68709A (en) 1995-07-28
AU661275B2 (en) 1995-07-20
PT97975B (pt) 1998-11-30
UA27043C2 (uk) 2000-02-28
PT97975A (pt) 1992-04-30

Similar Documents

Publication Publication Date Title
SK280564B6 (sk) Injekčný prípravok so spomaleným uvoľňovaním účinn
KR0157438B1 (ko) 주사가능한 서서히 방출하는 게이렌 약제
DE69934099T2 (de) Stabile geformte teilchen kristalliner organischer verbindungen
MXPA01002323A (es) Microparticulas.
CN114748428A (zh) 一种高载药量的盐酸卡利拉嗪长效缓释微球及其制备方法